P
Plcoskin
Improve the quality of human life through businesses such as biotechnology, and strives to become a leading company in the true future
About Plcoskin
Plcoskin operates in the bio industry, focusing on regenerative medicine technology to improve human life. The company engages in research and development of next-generation regenerative skin, fillers, and breast prostheses. Plcoskin's target clients include medical professionals, cosmetic surgeons, and patients seeking advanced medical and cosmetic solutions. The company operates in the global healthcare and cosmetic markets, leveraging cutting-edge technology and patient-centric research to develop its products. Plcoskin's business model revolves around the sale of its innovative medical and cosmetic products, including its proprietary cosmetic brand, YOULIEF. Revenue is generated through direct sales to healthcare providers and partnerships with medical institutions. The company is committed to exploring new markets within the bio industry, maintaining a leadership position through continuous innovation and technological advancements.
Source: Dealroom company dataAt a glance
- Founded
- 2017
- Headquarters
- Seoul, South Korea
- Sector
- Legal
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
HG Initiative
Series A6 investors entered at this stage
Primer- TITONY Investment
- SISJ Venture Investment
We Ventures- HIHelio Investment
STIC Ventures
Series B and later2 investors entered at this stage
SBI Investment
Highlight Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Plcoskin on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Plcoskin on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.